BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33441447)

  • 1. Estimating the percentage of European MSM eligible for PrEP: insights from a bio-behavioural survey in thirteen cities.
    Cordioli M; Gios L; Huber JW; Sherriff N; Folch C; Alexiev I; Dias S; Nöstlinger C; Gama A; Naseva E; Valkovičová Staneková D; Marcus U; Schink SB; Rosinska M; Blondeel K; Toskin I; Mirandola M
    Sex Transm Infect; 2021 Nov; 97(7):534-540. PubMed ID: 33441447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using data from a behavioural survey of men who have sex with men (MSM) to estimate the number likely to present for HIV pre-exposure prophylaxis (PrEP) in Ireland, 2017.
    Nic Lochlainn L; O'Donnell K; Hurley C; Lyons F; Igoe D
    Euro Surveill; 2017 Nov; 22(48):. PubMed ID: 29208157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017).
    Annequin M; Villes V; Delabre RM; Alain T; Morel S; Michels D; Schmidt AJ; Velter A; Rojas Castro D
    AIDS Care; 2020 May; 32(sup2):47-56. PubMed ID: 32189518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin.
    Ahouada C; Diabaté S; Mondor M; Hessou S; Guédou FA; Béhanzin L; Batona G; Gning NN; Zannou DM; Alary M
    BMC Public Health; 2020 Aug; 20(1):1267. PubMed ID: 32819335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: implications for disparities.
    Snowden JM; Chen YH; McFarland W; Raymond HF
    Sex Transm Infect; 2017 Feb; 93(1):52-55. PubMed ID: 27356041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities.
    Marcus U; Nöstlinger C; Rosińska M; Sherriff N; Gios L; Dias SF; Gama AF; Toskin I; Alexiev I; Naseva E; Schink SB; Mirandola M;
    BMC Infect Dis; 2018 Aug; 18(1):368. PubMed ID: 30081839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying unmet prevention needs among MSM in Europe through a multi-site bio-behavioural survey.
    Mirandola M; Gios L; Sherriff N; Marcus U; Toskin I; Rosinska M; Schink S; Kühlmann-Berenzon S; Suligoi B; Folch C; Nöstlinger C; Dias S; Stanekova D; Klavs I; Caplinskas S; Rafila A; Marin C; Alexiev I; Zohrabyan L; Noori T; Menel-Lemos C;
    Euro Surveill; 2018 Dec; 23(49):. PubMed ID: 30621823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017.
    Sullivan PS; Sanchez TH; Zlotorzynska M; Chandler CJ; Sineath RC; Kahle E; Tregear S
    J Int AIDS Soc; 2020 Mar; 23(3):e25461. PubMed ID: 32153119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
    Lim SH; Mburu G; Bourne A; Pang J; Wickersham JA; Wei CKT; Yee IA; Wang B; Cassolato M; Azwa I
    PLoS One; 2017; 12(9):e0182838. PubMed ID: 28902857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the size of HIV-negative MSM population that would benefit from pre-exposure prophylaxis in Florida.
    Mauck DE; Fennie KP; Ibañez GE; Fenkl EA; Sheehan DM; Maddox LM; Spencer EC; Trepka MJ
    Ann Epidemiol; 2020 Apr; 44():52-56. PubMed ID: 32145998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demand for pre-exposure prophylaxis for HIV and the impact on clinical services: Scottish men who have sex with men perspectives.
    Gilson RI; Clutterbuck DJ; Chen ZE
    Int J STD AIDS; 2018 Mar; 29(3):273-277. PubMed ID: 28771076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand.
    Yang D; Chariyalertsak C; Wongthanee A; Kawichai S; Yotruean K; Saokhieo P; Guadamuz T; Suwanvanichkij V; Beyrer C; Chariyalertsak S
    PLoS One; 2013; 8(10):e76650. PubMed ID: 24116132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM).
    Elsesser SA; Oldenburg CE; Biello KB; Mimiaga MJ; Safren SA; Egan JE; Novak DS; Krakower DS; Stall R; Mayer KH
    AIDS Behav; 2016 Jul; 20(7):1400-7. PubMed ID: 26538056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.
    Chang HH; Kim SW; Jung H; Lee SA; Park HK; Kim S; Lee JM; Choi JY
    J Korean Med Sci; 2018 Mar; 33(12):e91. PubMed ID: 29542300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.
    Prescott MR; Hern J; Petersen M; Santos GM
    AIDS Patient Care STDS; 2019 Apr; 33(4):167-174. PubMed ID: 30932698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
    Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
    J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies.
    Wilson EC; Turner CM; Arayasirikul S; Lightfoot M; Scheer S; Raymond HF; Liu A
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25539. PubMed ID: 32602642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014.
    Chen YH; Snowden JM; McFarland W; Raymond HF
    AIDS Behav; 2016 Dec; 20(12):2791-2797. PubMed ID: 26983951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.
    Hoots BE; Finlayson T; Nerlander L; Paz-Bailey G;
    Clin Infect Dis; 2016 Sep; 63(5):672-7. PubMed ID: 27282710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.